{"id":1960,"date":"2018-10-17T18:27:07","date_gmt":"2018-10-17T23:27:07","guid":{"rendered":"http:\/\/cru.mcgill.ca\/?p=1960"},"modified":"2018-11-07T18:38:59","modified_gmt":"2018-11-07T23:38:59","slug":"the-first-on-the-intrago-brain-tumour-trial-in-canada","status":"publish","type":"post","link":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/","title":{"rendered":"The first on the INTRAGO brain tumour trial in Canada"},"content":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; fullwidth=&#8221;on&#8221; _builder_version=&#8221;3.0.51&#8243; next_background_color=&#8221;#000000&#8243;][et_pb_fullwidth_menu menu_id=&#8221;15&#8243; submenu_direction=&#8221;downwards&#8221; fullwidth_menu=&#8221;off&#8221; dropdown_menu_text_color=&#8221;#ffffff&#8221; mobile_menu_bg_color=&#8221;rgba(0,0,0,0.67)&#8221; _builder_version=&#8221;3.2.2&#8243; menu_text_color=&#8221;#ffffff&#8221; menu_font_size=&#8221;17px&#8221; background_color=&#8221;rgba(0,0,0,0.67)&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; background_layout=&#8221;dark&#8221; \/][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; _builder_version=&#8221;3.0.47&#8243; custom_padding=&#8221;40px|0px|54px|0px|false|false&#8221; prev_background_color=&#8221;#000000&#8243;][et_pb_row _builder_version=&#8221;3.0.48&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; custom_padding=&#8221;0|0px|27px|0px|false|false&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_text _builder_version=&#8221;3.12.2&#8243;]<\/p>\n<h1>The first on the INTRAGO brain tumour trial in Canada<!--:--><!--:fr--> Le premier de l&#8217;essai INTRAGO sur les tumeurs c\u00e9r\u00e9brales au Canada<\/h1>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;3.12.2&#8243;]<\/p>\n<p>Glioblastoma Multiforme is grade IV brain cancer that is very aggressive. There are currently no cure but research is advancing to find new ways to prolong life expectancy for these patients. <a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02414165\" target=\"_blank\" rel=\"noopener\">The INTRAGO trial<\/a> (presented in this video) is important because it is trying to use intra-operative radiation therapy to delay the growth of cancer cells between the time patient receive surgery and their first treatment of combined radiotherapy\/chemotherapy.<\/p>\n<p>[\/et_pb_text][et_pb_image _builder_version=&#8221;3.12.2&#8243; src=&#8221;http:\/\/cru.mcgill.ca\/wp-content\/uploads\/TVA-une-premiere-au-canada.jpg&#8221; align=&#8221;center&#8221; url=&#8221;https:\/\/www.tvanouvelles.ca\/2018\/10\/17\/une-premiere-a-linstitut-neurologique-de-montreal&#8221; url_new_window=&#8221;on&#8221; \/][et_pb_button _builder_version=&#8221;3.12.2&#8243; button_text=&#8221;Current Recruiting Studies&#8221; button_url=&#8221;http:\/\/cru.mcgill.ca\/?page_id=701&#8243; button_alignment=&#8221;center&#8221; \/][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our Story What is a Clinical Trial? Trials Recruiting ALS Brain Tumour Dementia Migraine Epilepsy Multiple Sclerosis Neuromuscular Movement Disorders Neuro-Surgery Neurovascular (Stroke) Intensive Care Unit (ICU) Meet the team News FR The first on the INTRAGO brain tumour trial in Canada Le premier de l&#8217;essai INTRAGO sur les tumeurs c\u00e9r\u00e9brales au Canada Glioblastoma Multiforme [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":1712,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[45],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The first on the INTRAGO brain tumour trial in Canada - Clinical Research Unit<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The first on the INTRAGO brain tumour trial in Canada - Clinical Research Unit\" \/>\n<meta property=\"og:description\" content=\"Our Story What is a Clinical Trial? Trials Recruiting ALS Brain Tumour Dementia Migraine Epilepsy Multiple Sclerosis Neuromuscular Movement Disorders Neuro-Surgery Neurovascular (Stroke) Intensive Care Unit (ICU) Meet the team News FR The first on the INTRAGO brain tumour trial in Canada Le premier de l&#8217;essai INTRAGO sur les tumeurs c\u00e9r\u00e9brales au Canada Glioblastoma Multiforme [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Research Unit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cru.mcgill\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-17T23:27:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-11-07T23:38:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cru.mcgill.ca\/wp-content\/uploads\/TVA-une-premiere-au-canada.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"940\" \/>\n\t<meta property=\"og:image:height\" content=\"529\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sophie Lorenzo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/cru.mcgill.ca\/#organization\",\"name\":\"Clinical Research Unit\",\"url\":\"https:\/\/cru.mcgill.ca\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/cru.mcgill\/\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\/\/cru.mcgill.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cru.mcgill.ca\/wp-content\/uploads\/CRUlogo.png\",\"contentUrl\":\"https:\/\/cru.mcgill.ca\/wp-content\/uploads\/CRUlogo.png\",\"width\":268,\"height\":150,\"caption\":\"Clinical Research Unit\"},\"image\":{\"@id\":\"https:\/\/cru.mcgill.ca\/#\/schema\/logo\/image\/\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cru.mcgill.ca\/#website\",\"url\":\"https:\/\/cru.mcgill.ca\/\",\"name\":\"Clinical Research Unit\",\"description\":\"CRU at the Neuro (Montreal Neurological Institute-Hospital)\",\"publisher\":{\"@id\":\"https:\/\/cru.mcgill.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cru.mcgill.ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/\",\"url\":\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/\",\"name\":\"The first on the INTRAGO brain tumour trial in Canada - Clinical Research Unit\",\"isPartOf\":{\"@id\":\"https:\/\/cru.mcgill.ca\/#website\"},\"datePublished\":\"2018-10-17T23:27:07+00:00\",\"dateModified\":\"2018-11-07T23:38:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/#breadcrumb\"},\"inLanguage\":\"en-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cru.mcgill.ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The first on the INTRAGO brain tumour trial in Canada\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/\"},\"author\":{\"name\":\"Sophie Lorenzo\",\"@id\":\"https:\/\/cru.mcgill.ca\/#\/schema\/person\/266a30ffc001c61839f97201c1f026a4\"},\"headline\":\"The first on the INTRAGO brain tumour trial in Canada\",\"datePublished\":\"2018-10-17T23:27:07+00:00\",\"dateModified\":\"2018-11-07T23:38:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/\"},\"wordCount\":285,\"publisher\":{\"@id\":\"https:\/\/cru.mcgill.ca\/#organization\"},\"articleSection\":[\"News-en\"],\"inLanguage\":\"en-CA\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cru.mcgill.ca\/#\/schema\/person\/266a30ffc001c61839f97201c1f026a4\",\"name\":\"Sophie Lorenzo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\/\/cru.mcgill.ca\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ab462456dff4c532792084271212e322?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ab462456dff4c532792084271212e322?s=96&d=mm&r=g\",\"caption\":\"Sophie Lorenzo\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The first on the INTRAGO brain tumour trial in Canada - Clinical Research Unit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/","og_locale":"en_US","og_type":"article","og_title":"The first on the INTRAGO brain tumour trial in Canada - Clinical Research Unit","og_description":"Our Story What is a Clinical Trial? Trials Recruiting ALS Brain Tumour Dementia Migraine Epilepsy Multiple Sclerosis Neuromuscular Movement Disorders Neuro-Surgery Neurovascular (Stroke) Intensive Care Unit (ICU) Meet the team News FR The first on the INTRAGO brain tumour trial in Canada Le premier de l&#8217;essai INTRAGO sur les tumeurs c\u00e9r\u00e9brales au Canada Glioblastoma Multiforme [&hellip;]","og_url":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/","og_site_name":"Clinical Research Unit","article_publisher":"https:\/\/www.facebook.com\/cru.mcgill\/","article_published_time":"2018-10-17T23:27:07+00:00","article_modified_time":"2018-11-07T23:38:59+00:00","og_image":[{"width":940,"height":529,"url":"https:\/\/cru.mcgill.ca\/wp-content\/uploads\/TVA-une-premiere-au-canada.jpg","type":"image\/jpeg"}],"author":"Sophie Lorenzo","twitter_card":"summary_large_image","twitter_misc":{"Written by":false,"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/cru.mcgill.ca\/#organization","name":"Clinical Research Unit","url":"https:\/\/cru.mcgill.ca\/","sameAs":["https:\/\/www.facebook.com\/cru.mcgill\/"],"logo":{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/cru.mcgill.ca\/#\/schema\/logo\/image\/","url":"https:\/\/cru.mcgill.ca\/wp-content\/uploads\/CRUlogo.png","contentUrl":"https:\/\/cru.mcgill.ca\/wp-content\/uploads\/CRUlogo.png","width":268,"height":150,"caption":"Clinical Research Unit"},"image":{"@id":"https:\/\/cru.mcgill.ca\/#\/schema\/logo\/image\/"}},{"@type":"WebSite","@id":"https:\/\/cru.mcgill.ca\/#website","url":"https:\/\/cru.mcgill.ca\/","name":"Clinical Research Unit","description":"CRU at the Neuro (Montreal Neurological Institute-Hospital)","publisher":{"@id":"https:\/\/cru.mcgill.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cru.mcgill.ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-CA"},{"@type":"WebPage","@id":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/","url":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/","name":"The first on the INTRAGO brain tumour trial in Canada - Clinical Research Unit","isPartOf":{"@id":"https:\/\/cru.mcgill.ca\/#website"},"datePublished":"2018-10-17T23:27:07+00:00","dateModified":"2018-11-07T23:38:59+00:00","breadcrumb":{"@id":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/#breadcrumb"},"inLanguage":"en-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cru.mcgill.ca\/"},{"@type":"ListItem","position":2,"name":"The first on the INTRAGO brain tumour trial in Canada"}]},{"@type":"Article","@id":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/#article","isPartOf":{"@id":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/"},"author":{"name":"Sophie Lorenzo","@id":"https:\/\/cru.mcgill.ca\/#\/schema\/person\/266a30ffc001c61839f97201c1f026a4"},"headline":"The first on the INTRAGO brain tumour trial in Canada","datePublished":"2018-10-17T23:27:07+00:00","dateModified":"2018-11-07T23:38:59+00:00","mainEntityOfPage":{"@id":"https:\/\/cru.mcgill.ca\/the-first-on-the-intrago-brain-tumour-trial-in-canada\/"},"wordCount":285,"publisher":{"@id":"https:\/\/cru.mcgill.ca\/#organization"},"articleSection":["News-en"],"inLanguage":"en-CA"},{"@type":"Person","@id":"https:\/\/cru.mcgill.ca\/#\/schema\/person\/266a30ffc001c61839f97201c1f026a4","name":"Sophie Lorenzo","image":{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/cru.mcgill.ca\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ab462456dff4c532792084271212e322?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ab462456dff4c532792084271212e322?s=96&d=mm&r=g","caption":"Sophie Lorenzo"}}]}},"_links":{"self":[{"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/posts\/1960"}],"collection":[{"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/comments?post=1960"}],"version-history":[{"count":2,"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/posts\/1960\/revisions"}],"predecessor-version":[{"id":1962,"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/posts\/1960\/revisions\/1962"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/media\/1712"}],"wp:attachment":[{"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/media?parent=1960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/categories?post=1960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cru.mcgill.ca\/wp-json\/wp\/v2\/tags?post=1960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}